TP53 Mutation Status Divides MDS Patients with Complex Karyotypes into Distinct Prognostic Risk Groups: Analysis of Combined Datasets from the International Working Group for MDS-Molecular Prognosis Committee Bejar, R., Papaemmanuil, E., Haferlach, T., Garcia-Manero, G., Maciejewski, J. P., Sekeres, M. A., Walter, M. J., Graubert, T. A., Cazzola, M., Malcovati, L., Campbell, P. J., Ogawa, S., Boultwood, J., Bowen, D., Tauro, S., Groves, M. J., Fontenay, M., Shih, L., Tuechler, H., Stevenson, K. E., Neuberg, D., Greenberg, P. L., Ebert, B. L. AMER SOC HEMATOLOGY. 2014

View details for Web of Science ID 000349233803090